Bristol Myers Squibb (CELG-RI) Tax Rate (2009 - 2026)
Bristol Myers Squibb (CELG-RI) posted quarterly Tax Rate of 18.84% for Q2 2026, down 710.0% year-over-year from 3.09% in Q2 2025, and up 8.84% quarter-over-quarter from 17.31% in Q1 2026.
Bristol Myers Squibb (CELG-RI) Tax Rate (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (CELG-RI) has reported Tax Rate for 18 consecutive years, with 18.84% the latest figure, recorded in Q2 2026.
- In Q2 2026, Tax Rate fell 710.0% year-over-year to 18.84%; the TTM figure through Jun 2026 stood at 22.12% (down 107.0% YoY), while the FY2025 annual figure was 24.36%, up 3097.0% from the prior year.
- Tax Rate rose to 18.84% in Q2 2026 per CELG-RI's latest filing, from 17.31% in the prior quarter.
- Across five years, Tax Rate topped out at 56.57% in Q4 2024 and bottomed at 30.95% in Q2 2024.
- Historically, Tax Rate has averaged 14.7% across 5 years, with a median of 18.5% in 2026.
- Annual changes were most pronounced in 2023 — Tax Rate sank 3874 bps — and 2024, when it soared 6183 bps.
- Bristol Myers Squibb's Tax Rate stood at 8.93% in 2022, then surged by 41 bps to 5.26% in 2023, then surged by 1176 bps to 56.57% in 2024, then slumped by 54 bps to 26.12% in 2025, then dropped by 28 bps to 18.84% in 2026.
- Business Quant data shows CELG-RI's Tax Rate at 18.84% in Q2 2026, 17.31% in Q1 2026, and 26.12% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 23.71% |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 10.40% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 14.20% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -2.36% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 62.33% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 56.21% |
| 10 | Bristol Myers Squibb | 224.21 Mn | -10.84 Bn | 9.25 Bn | 18.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.84% |
| Jun 30, 2026 | 18.84% |
| Jun 30, 2026 | 18.84% |
| Mar 31, 2026 | 17.31% |
| Mar 31, 2026 | 17.31% |
| Mar 31, 2026 | 17.31% |
| Dec 31, 2025 | 26.12% |
| Dec 31, 2025 | 26.12% |
| Dec 31, 2025 | 26.12% |
| Sep 30, 2025 | 29.51% |
| Sep 30, 2025 | 29.51% |
| Sep 30, 2025 | 29.51% |
| Jun 30, 2025 | 25.94% |
| Jun 30, 2025 | 25.94% |
| Jun 30, 2025 | 25.94% |
| Mar 31, 2025 | 17.13% |
| Mar 31, 2025 | 17.13% |
| Mar 31, 2025 | 17.13% |
| Dec 31, 2024 | 56.57% |
| Dec 31, 2024 | 56.57% |